Hanmi Pharm. Co., Ltd. (KRX:128940)
244,000
-5,500 (-2.20%)
Mar 11, 2025, 9:00 AM KST
Hanmi Pharm. Revenue
In the year 2024, Hanmi Pharm. had annual revenue of 1.50T KRW with 0.31% growth. Hanmi Pharm. had revenue of 351.61B in the quarter ending December 31, 2024, a decrease of -16.75%.
Revenue
1,495.50B
Revenue Growth
+0.31%
P/S Ratio
2.06
Revenue / Employee
641.85M
Employees
2,330
Market Cap
3,081.29B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,495.50B | 4.61B | 0.31% |
Dec 31, 2023 | 1,490.89B | 159.34B | 11.97% |
Dec 31, 2022 | 1,331.55B | 128.36B | 10.67% |
Dec 31, 2021 | 1,203.19B | 127.33B | 11.84% |
Dec 31, 2020 | 1,075.85B | -37.80B | -3.39% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 2,876.25B |
ALTEOGEN | 74.38B |
HLB Co., Ltd. | 51.92B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
Sam Chun Dang Pharm. | 208.22B |
LigaChem Biosciences | 101.42B |